跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rx-kinase
首页
药物
Rx-kinase
Rx-kinase
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pyrazole compounds useful as protein kinase inhibitors
US 7625913 B2
申请人: VERTEX PHARMA
优先权: 2001
US
9 件公开
US 7691853 B2
申请人: VERTEX PHARMA
优先权: 2001
US
4 件公开
US 6610677 B2
申请人: VERTEX PHARMA
优先权: 2001
US
2 件公开
US 6613776 B2
申请人: VERTEX PHARMA
优先权: 2001
US
2 件公开
3-BENZOYL-1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS MKK4 INHIBITORS FOR TREATING LIVER DISEASES
US 2023088395 A1
申请人: HEPAREGENIX GMBH
优先权: 2020
CN
EP
US
WO
5 件公开
Triazole compounds useful as protein kinase inhibitors
US 7951820 B2
申请人: VERTEX PHARMA
优先权: 2001
US
4 件公开
Quinazoline derivatives having tyrosine kinase inhibitory activity
US 8202879 B2
申请人: KUME MASAHARU
优先权: 2005
US
4 件公开
5-CYANO-1H-IMIDAZOLE-2-CARBOXAMIDE COMPOUNDS AS CSF1R INHIBITORS
EP 4709719 A1
申请人: MODULO BIO INC
优先权: 2023
CN
EP
WO
3 件公开
Fused heterocyclic compounds as RET kinase inhibitors
US 11964988 B2
申请人: ARRAY BIOPHARMA INC
优先权: 2018
CN
US
2 件公开
Purine derivatives, preparation method and use as medicines
US 7041824 B2
申请人: AVENTIS PHARMA SA
优先权: 2000
US
4,6-disubstituted pyrimidines useful as kinase inhibitors
US 7989465 B2
申请人: AVILA THERAPEUTICS INC
优先权: 2009
US
2,4-disubstituted pyrimidines useful as kinase inhibitors
US 8450335 B2
申请人: SINGH JUSWINDER
优先权: 2009
US
US 8338439 B2
申请人: SINGH JUSWINDER
优先权: 2009
US
Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
US 11912701 B2
申请人: HEPAREGENIX GMBH
优先权: 2018
US
药物
反馈